Emergent Biosolutions Inc Strategic Asset Allocation Index
Emergent Biosolutions Inc strategic asset allocation index. Emergent Biosolutions Inc (EBS) has a Strategic Asset Allocation Index of 41.3% as of December 2025. Strategic assets (PP&E of $216.00 Million plus long-term investments of $-) total $216.00 Million, measured against net assets of $522.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Emergent Biosolutions Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Emergent Biosolutions Inc (2004–2025)
Strategic asset allocation index of Emergent Biosolutions Inc from 2004 to 2025. This chart shows how Emergent Biosolutions Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 41.3%, representing strategic assets of $216.00 Million against net assets of $522.60 Million USD. Check Emergent Biosolutions Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Emergent Biosolutions Inc Strategic Asset Allocation Index by Year (2004–2025)
Emergent Biosolutions Inc strategic asset allocation index by year from 2004 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Emergent Biosolutions Inc from 2004 to 2025, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Emergent Biosolutions Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.3% | $216.00 Million | $216.00 Million | $- | $522.60 Million | ▼ -17.1 pp |
| 2024 | 58.5% | $282.30 Million | $282.30 Million | $- | $482.80 Million | ▼ -3.0 pp |
| 2023 | 61.5% | $399.00 Million | $399.00 Million | $- | $649.30 Million | ▲ +2.5 pp |
| 2022 | 58.9% | $817.60 Million | $817.60 Million | $- | $1.39 Billion | ▲ +9.3 pp |
| 2021 | 49.6% | $800.10 Million | $800.10 Million | $- | $1.61 Billion | ▲ +5.1 pp |
| 2020 | 44.5% | $644.10 Million | $644.10 Million | $- | $1.45 Billion | ▼ -5.3 pp |
| 2019 | 49.8% | $542.30 Million | $542.30 Million | $- | $1.09 Billion | ▼ -0.6 pp |
| 2018 | 50.5% | $510.20 Million | $510.20 Million | $- | $1.01 Billion | ▲ +5.8 pp |
| 2017 | 44.6% | $407.21 Million | $407.21 Million | $- | $912.35 Million | ▼ -18.5 pp |
| 2016 | 63.1% | $376.45 Million | $376.45 Million | $- | $596.21 Million | ▲ +12.9 pp |
| 2015 | 50.3% | $331.86 Million | $331.86 Million | $- | $660.02 Million | ▼ -6.5 pp |
| 2014 | 56.8% | $313.98 Million | $313.98 Million | $- | $553.20 Million | ▲ +2.7 pp |
| 2013 | 54.0% | $264.24 Million | $264.24 Million | $- | $489.17 Million | ▼ -0.7 pp |
| 2012 | 54.7% | $241.76 Million | $241.76 Million | $- | $442.13 Million | ▲ +4.5 pp |
| 2011 | 50.1% | $208.97 Million | $208.97 Million | $- | $416.73 Million | ▲ +9.3 pp |
| 2010 | 40.9% | $152.70 Million | $152.70 Million | $- | $373.56 Million | ▼ -13.2 pp |
| 2009 | 54.1% | $131.83 Million | $131.83 Million | $- | $243.81 Million | ▼ -8.5 pp |
| 2008 | 62.5% | $124.66 Million | $124.66 Million | $- | $199.35 Million | ▼ -1.9 pp |
| 2007 | 64.4% | $110.22 Million | $110.22 Million | $- | $171.16 Million | ▲ +7.9 pp |
| 2006 | 56.5% | $78.17 Million | $78.17 Million | $- | $138.47 Million | ▲ +5.2 pp |
| 2005 | 51.3% | $30.64 Million | $30.64 Million | $- | $59.74 Million | ▼ -67.5 pp |
| 2004 | 118.8% | $27.27 Million | $27.27 Million | $- | $22.95 Million | — |